Biotechnology company Nuclera has introduced an antibody screening service to enable quick access to high-quality proteins and advance AI-driven discovery. “Antibodies are one of the most important ...

Sino Biological, the regional subsidiary of global life science reagent and service provider Sino Biological, has recently ...

In April 2025, the US Food and Drug Administration (FDA) announced plans to phase out certain animal testing requirements, ...

Suzhou Ribo Life Science and Ribocure Pharmaceuticals have achieved their third milestone in the research collaboration with Boehringer Ingelheim to discover novel therapies for liver disease, ...

Through this agreement, Cellular Intelligence will advance the continued clinical development of the cell therapy Parkinson’s program and provide disease-modifying therapy for p ...

Leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and research, Axol Bioscience, today announced that it has acquired the ophthalmology business of Newcells ...

Respiratory syncytial virus (RSV) is a highly contagious, seasonal pathogen and a leading global cause of acute lower respiratory infections (ALRIs). Globally, RSV is responsible for an immense health ...

Molecular genomics technology provider Agena Bioscience has launched the CFTR 100+ panel, a multiplex genotyping solution designed to provide expanded coverage of CFTR variants. “With evolving CFTR ...

Quotient Sciences, an integrated Contract Research, Development and Manufacturing Organisation, has extended its commercial supply partnership with Ipsen, a global biopharmaceutical company, to ...

Navinci has launched Omni, a breakthrough fully customised kit created to transform how scientists study protein function in tissue. Omni provides advanced spatial interactomics capabilities, enabling ...